Digestive health

Which Type of IBS Do I Have? Finding Your Subtype Among C, D, M and U

Save

Four labels — IBS-C, IBS-D, IBS-M, IBS-U — describe one condition sorted by bowel pattern. The sorting rule is narrower than most people expect: it looks only at stool form, only on abnormal days, and it uses a seven-point picture scale rather than a description. Here is how the rule works, how to run the two-week count yourself, and what the answer changes about treatment.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What actually decides your IBS subtype?

Subtype is decided by stool form — the physical shape and consistency of what comes out — on the days when your bowel habit is abnormal. It is not decided by how many times a day you go, how urgent it feels, how much you bloat, or how badly it hurts. Those things shape a life far more than the label does. They simply are not what the sorting rule looks at.

That narrowness is deliberate. The formal definition used in research and in most clinics, the Rome IV criteria, first establishes that a person has IBS at all — recurrent abdominal pain tied to defecation and to changes in stool frequency or form — and only then sorts them by pattern. Pain is the entry requirement, not the sorting key. Whether that pain requirement is what separates IBS from a bowel habit anyone might have belongs to the wider question of ibs as a diagnosis, not to this page.

The second piece of narrowness catches almost everyone out. Only abnormal days are counted. If your bowels behave for four days a week and misbehave for three, the four good days drop out of the arithmetic entirely and the sorting happens inside the three. This is why people whose bowels are fine most of the time still land squarely in IBS-C or in the ibs-d subtype. The question the criteria ask is never how much of your life is disrupted — only what the disrupted days look like.

The subtype describes the shape of your stool on bad days. It says nothing about how many bad days you have.

How the Bristol Stool Scale works

The Bristol Stool Form Scale is a single-item, seven-point picture scale 1. Type 1 is separate hard lumps, hard to pass. Type 7 is entirely liquid with no solid pieces. The five types in between run in order through lumpy sausage, cracked sausage, smooth and soft, soft blobs with clear edges, and fluffy ragged pieces. Higher numbers mean looser stool. All four IBS subtypes are defined in this scale's language, which is why a bristol stool chart is the first thing a gastroenterology visit tends to produce.

It earns that job because form tracks transit. In the paper that validated it, whole-gut transit time was measured in 66 volunteers using radiopaque markers, then deliberately shifted with senna or loperamide and measured again. Stool form correlated with baseline transit better than any other measure the researchers took (r = -0.54), and change in form tracked change in transit better than change in stool frequency did (r = -0.65) 1. The relationship runs inverse. The higher the Bristol score, the faster material moved through the gut 1.

Two limits are worth knowing, because both are widely misstated. First, the scale measures one thing and diagnoses nothing on its own: a type 7 stool means fast transit, not IBS. Second, the familiar cutoffs everybody quotes — types 1 and 2 count as constipation, types 6 and 7 count as diarrhoea — are not from the validation study at all. They are a later convention layered on top of a scale that was built to measure transit time. The scale is a measurement; the cutoffs are a useful agreement about where to draw lines on it.

The four subtypes, side by side

There are four labels and every person with IBS receives one of them: IBS-C (constipation-predominant), IBS-D (diarrhoea-predominant), IBS-M (mixed) and IBS-U (unclassified). Symptoms differ meaningfully depending on which type a person has, which is why the label gets asked for at nearly every appointment 2. In the formal criteria, the dividing line sits at roughly one quarter of abnormal days falling at each end of the scale.

SubtypeWhat the abnormal days showThe everyday version
IBS-CMostly hard or lumpy stool, Bristol 1-2; loose days are rare visitorsStraining, a sense of never quite finishing, days between movements, bloating that builds through the day
IBS-DMostly loose or watery stool, Bristol 6-7; hard days are rare visitorsUrgency, mapping bathrooms before leaving the house, several movements clustered after waking or after meals
IBS-MBoth ends turn up often — hard days and loose days inside the same fortnightThe sense of having two conditions taking turns; what settles one direction can push the other
IBS-UThe person meets the criteria for IBS, but the abnormal days do not pile up at either endA genuinely erratic pattern, or too few abnormal days inside the counting window to sort

The labels are shorthand for direction of travel, not for severity. Someone with IBS-C can be far more limited by their symptoms than someone with IBS-D, and the reverse is just as common. Nothing about the letter predicts how bad a case is, how long it has run, or how it will respond to treatment.

Why the mixed subtype is so easy to mis-assign

Mixed IBS is common, and it is also the label people land on by accident. A two-week count is a photograph, and several ordinary things push the photograph away from the underlying pattern — most of them involving something that altered transit during the window without anyone thinking of it as an interference.

  • A laxative or an antidiarrhoeal inside the window. The Bristol scale was validated partly by moving transit on purpose with senna and loperamide and watching the score move with it 1. A medicine that is working has, by design, changed the number about to be written down.
  • A flare that straddles the fortnight. Two weeks chosen during a bad stretch describes the bad stretch faithfully and the year poorly.
  • Counting the middle of the scale. Types 3, 4 and 5 are neither end. Including them dilutes the count and pushes an otherwise clear pattern towards unclassified.
  • A stomach bug, a course of antibiotics, or travel. Each moves transit for reasons that have nothing to do with IBS.
  • Genuine alternation. Some people really do swing between both ends within days. That is IBS-M, and it is not a counting error.

Because of all this, clinicians usually ask about the shape of the pattern over months as well as reading the diary fortnight, and they ask what was being taken during it.

A mixed pattern is not a sign of a more serious or more complicated illness. It is a description of variability, and nothing more.

Running the count so the answer is usable

A usable stool diary records four things for each bowel movement: the date, the Bristol type read off the chart, whether that day counted as abnormal, and anything that could have shifted transit — a laxative, an antidiarrhoeal, antibiotics, an infection, a trip. Two weeks is the usual window. Four weeks is better when the pattern swings, when a flare has only just settled, or when a first count came back unclassified.

The reason it is worth the trouble is that the diagnosis itself now leans on the pattern. Current guideline advice favours a positive diagnostic strategy — making the diagnosis from the symptom pattern with limited testing, rather than treating IBS as the leftover after an exhaustive search for something else 3. A diary is the raw material for that strategy. Without one, the appointment runs on recall, and recall over-weights the worst week of the last six months.

The same diary doubles as a baseline. Because stool form is responsive to change rather than fixed 1, repeating the identical count after a change in diet or medication shows whether anything actually moved, in a unit both patient and clinician read the same way. That is a more honest read than trying to remember in November whether September was better.

What to bring, in practice: the raw daily entries rather than a summary, the medication notes alongside them, and the date the current pattern started — which is often the single most useful fact in the whole record.

What the subtype actually changes about treatment

The label matters because a large share of IBS treatment is subtype-directed. Guideline recommendations split by direction of travel: secretagogues — drugs that draw water into the bowel — for constipation-predominant disease, the poorly absorbed antibiotic rifaximin for IBS without constipation, and gut-directed psychotherapy across subtypes 3. Getting the letter wrong points a prescriber at the wrong shelf, and a drug aimed at the opposite direction does not merely fail to help.

That is the practical reason clinicians want the count before writing anything, and it is why ibs medications are discussed by subtype rather than as one list. What each class was actually tested on, and how large the effects were, is its own subject.

Diet runs the other way — it is largely subtype-agnostic. FODMAPs are fermentable oligosaccharides, disaccharides, monosaccharides and polyols: short-chain carbohydrates that are poorly absorbed in the small intestine. The group that first described the approach puts the proportion of people with IBS whose symptoms improve on a low FODMAP diet at roughly three in four 4. It is not meant to be permanent. Best-practice advice describes three phases: a restriction phase of about four to six weeks, then structured reintroduction, then personalisation down to the smallest restriction that holds symptoms 5.

The reintroduction phase is the one people skip, and skipping it leaves someone eating a narrow diet indefinitely for no added benefit. That phase is most of what a gi dietitian for ibs is actually doing over those weeks 5. Where probiotics for ibs fit is a separate evidence question, and it does not turn on subtype either.

Your subtype can change, and usually will

Subtype is a snapshot, not a diagnosis inside a diagnosis. The scale it rests on was built to be responsive: shift transit and the score shifts with it, reliably enough that the shift is what the validation study measured 1. So a person who counts as IBS-C in March can count as IBS-M in September without anything having gone wrong and without the first assessment having been an error.

Treatment itself moves the label. Somebody doing well on a secretagogue for IBS-C may count as mixed while it is working — which is exactly what success looks like, not a reclassification. Illness, pregnancy, a change in fibre, a stressful season and simple ageing all move it too. What clinicians are usually trying to see underneath is the untreated pattern.

It is also worth being clear about what the letter does not carry. It does not tell you how severe your IBS is, what caused it, how long it will last, whether it will respond to any particular treatment, or whether anything is being missed. Among the ibs subtypes, none is the mild one and none is the serious one. The label is a routing decision about which treatments to try first.

Two counts a season apart describe a pattern. One count describes a fortnight.

When the pattern is not IBS at all

Some symptoms sit outside the subtype question entirely, because they are not features of IBS and no subtype explains them. Bleeding from the rectum or blood in the stool, abdominal pain that is constant rather than coming and going around bowel movements, vomiting, being unable to pass gas, and weight coming off without trying are all listed as reasons to be evaluated promptly rather than reasons to keep counting 6. A family history of colorectal cancer lowers the threshold further 6.

Each of those symptoms has explanations that are common and not dangerous. That is not a reason to wait. A benign explanation is a conclusion a clinician reaches after looking, not one a reader can reach from a description, and the cost of guessing wrong is a delayed diagnosis of something treatable. New rectal bleeding is a this-week appointment, not a wait-and-see. Weight loss that nobody is trying to produce is the same.

The diary and the appointment are not alternatives. The two-week count is useful to bring to that visit and useless as a reason to postpone it. If an alarm symptom appears midway through the counting window, the count stops being the priority.

One more boundary: an established IBS label does not immunise anyone against developing something else. A bowel habit that has been stable for years and then changes decisively over a few weeks is a change worth reporting, whichever letter is on the chart.

Common questions

Yes, and most people with IBS-C do. The label describes where the abnormal days cluster, not what happens on every one of them. A run of loose days inside an otherwise constipated fortnight is ordinary. It only changes the label when both directions turn up often enough that neither one dominates the count, which is what mixed IBS means.

No. It measures one thing, stool form, and form is a marker of how fast material moves through the gut. A week of type 7 stool describes fast transit, not a diagnosis: infection, medication, coeliac disease and inflammatory bowel disease can all produce it. The scale sorts IBS once IBS has been established. It cannot establish it.

Unclassified means the abnormal days did not pile up at either end of the scale often enough to sort. It is a filing outcome rather than a severity grade, and it does not mean the case is unusual or harder to treat. A longer counting window, or one taken outside a flare, often resolves it into one of the other three.

They are worth recording and worth flagging, because the medicine has changed the very thing being measured. Stool form moves predictably when transit is altered on purpose, which is exactly what those drugs do. A count taken while treatment is working describes the treatment. Clinicians usually want the untreated pattern, so the notes matter as much as the numbers.

Two weeks is the common window and is usually enough when the pattern is stable. Four weeks is more informative when bowel habit swings, when a flare has just ended, or when a first count landed on unclassified. Longer windows also survive the ordinary disruptions — a trip, a stomach bug, a course of antibiotics — that distort a short one.

Less than most people expect. The main dietary approach in IBS targets fermentable carbohydrates rather than a subtype, and it runs in phases with a reintroduction step rather than as a permanent restriction. Fibre type and fluid tend to differ more by direction of travel, and that conversation usually happens with a dietitian rather than from a printed list.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When counting stops and an appointment starts

  • Blood in the stool, blood on the paper, or bleeding from the rectum — at any age, and at any point during a counting window
  • Weight coming off without anyone trying to produce it, particularly alongside a bowel habit that changed over weeks rather than years
  • Abdominal pain that stays constant instead of easing and returning around bowel movements
  • Vomiting, or being unable to pass gas or stool at all while the abdomen is painful and distended

Heavy rectal bleeding — soaking the bowl, passing clots, or bleeding alongside light-headedness, fainting or a racing pulse — is an emergency department visit or a 911 call, not an appointment.

This page explains how IBS subtypes are defined and how the counting works. It is education, not a diagnosis and not a treatment plan. Only a clinician who can examine you and see your history can tell you what your symptoms mean or what to do about them.

References

  1. 1.Lewis SJ, Heaton KW. (1997). Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology 1997;32(9):920-924. doi:10.3109/00365529709011203That the Bristol Stool Form Scale is a single-item, seven-point ordinal scale running from type 1 to type 7; that higher scores mean looser stool and faster whole-gut transit while lower scores mean harder stool and slower transit; that stool form correlated with baseline whole-gut transit time better than any other measure taken (r = -0.54) and that change in form tracked change in transit better than change in stool frequency did (r = -0.65) in 66 volunteers whose transit was deliberately altered with senna or loperamide; and that the scale is responsive to change and can therefore be used to monitor change in intestinal function.
  2. 2.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2017). Symptoms & Causes of Irritable Bowel Syndrome. NIDDK, National Institutes of Health. linkThe names of the IBS subtypes — IBS with constipation, IBS with diarrhoea, and mixed IBS — and that IBS symptoms differ depending on which type a person has.
  3. 3.Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B (2021). ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. doi:10.14309/ajg.0000000000001036That IBS is diagnosed with a positive diagnostic strategy based on the symptom pattern with limited testing rather than as a diagnosis of exclusion, and that pharmacologic and psychological treatment is directed by subtype — secretagogues for constipation-predominant IBS, rifaximin for IBS without constipation, and gut-directed psychotherapy across subtypes.
  4. 4.Monash University, Department of Gastroenterology (2024). About FODMAPs and IBS. Monash University (Monash FODMAP). linkThe definition of FODMAPs as fermentable oligosaccharides, disaccharides, monosaccharides and polyols, and the originating institution's estimate that roughly three in four people with IBS see symptom improvement on a low FODMAP diet.
  5. 5.Chey WD, Hashash JG, Manning L, Chang L (2022). AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review. Gastroenterology. PMID 35337654That the low FODMAP diet is delivered in three phases — restriction for roughly four to six weeks, structured reintroduction, then personalisation — and is best carried out with a registered dietitian rather than self-directed.
  6. 6.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2018). Symptoms & Causes of Constipation. NIDDK, National Institutes of Health. linkThe enumeration of bowel symptoms that warrant prompt medical evaluation rather than continued self-monitoring: rectal bleeding, blood in the stool, constant abdominal pain, inability to pass gas, vomiting, and unintentional weight loss, together with a family history of colorectal cancer as an additional reason to be seen.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy